How to enter
Entries are now closed
Over the last few years, the NHS has increasingly worked with pharmaceutical companies to deliver improved services to patients. Partnerships between trusts and the pharma industry are varied and represent a range of projects from access and treatment pathways to service and capacity improvements.
The judges will be looking for innovative projects which demonstrate best practice and deliver benefits which would have been impossible for the NHS to do by itself. They are likely to deal with a specific patient group and could include audit and data analysis; care co-ordination and new pathways for patients. As well as helping the NHS provide better services within financial constraints, they should offer ongoing benefits after any initial set up period. Crucially, they must add value and not just replicate something the NHS could do for itself.
- Pharmaceutical companies supplying services in partnership with NHS organisations
- Single partnership or joint working projects
- Any size of project may apply, and judges will be reviewing impact and efficacy
- Project must be ongoing or should have been completed with results relevant to the past two years up until the awards deadline date